These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6797689)

  • 21. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
    Miyata H; Himeno K; Nomoto K
    Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma.
    Karakousis CP; Didolkar MS; Han T
    Cancer Treat Rep; 1981; 65(9-10):925-6. PubMed ID: 7273032
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
    Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
    Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose, route, and time dependence of serum lysozyme and antitumor activity following administration of glucan, Corynebacterium parvum, pyran, or lipopolysaccharide to mice.
    Gorecka-Tisera A; Proctor JW; Yamamura Y; Harnaha J; Meinert K
    J Natl Cancer Inst; 1981 Oct; 67(4):911-5. PubMed ID: 6944557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-immunotherapeutic efficacy of Serratia marcescens polyribosomes.
    Urban RW; Edwards BS; Segal W
    Cancer Res; 1980 May; 40(5):1501-5. PubMed ID: 6154530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Protective action of arginine (or lysine) butyrate against the lethal effect of encelphalomyocarditis virus on mice].
    Chany C; Cerutti I
    C R Seances Acad Sci III; 1981 Jul; 293(1):49-51. PubMed ID: 6272953
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of cytokines concentration and percentage of survival of rabies virus-infected mice submitted to anti-rabies Vero-cell propagated vaccine and P. acnes.
    Megid J; Appolinario CM; Mazzini AM; Almeida MF
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):192-6. PubMed ID: 16930720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacies of plant phenolic compounds on sodium butyrate induced anti-tumour activity.
    Indap MA; Barkume MS
    Indian J Exp Biol; 2003 Aug; 41(8):861-4. PubMed ID: 15248485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxorubicin, cisplatin, and Corynebacterium parvum in non-small cell bronchogenic carcinoma.
    Drapkin R; Bjornsson S; Naeher C; Higby D; Caracandas J; Wallens WT; Kuberka N; Suh K; Siddiqi N; Henderson ES
    Cancer Treat Rep; 1980; 64(12):1367-9. PubMed ID: 7193520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.
    Chen L; McGowan P; Ashe S; Johnston JV; Hellström I; Hellström KE
    Cancer Res; 1994 Oct; 54(20):5420-3. PubMed ID: 7522958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-cell Corynebacterium parvum generated by nanotechnology: a promising immunomodulator with less side effects.
    Gao S; Liu C; Qu S; Song J; Li J; Zhang P; Wang Q; Guo C; Gao F; Zhang L
    Int Immunopharmacol; 2007 Oct; 7(10):1334-42. PubMed ID: 17673148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the toxicity of two formulations of Corynebacterium parvum in a double-blind crossover trial in patients with bronchogenic carcinoma.
    Mitcheson HD; Priestman TJ
    Clin Oncol; 1981 Sep; 7(3):179-82. PubMed ID: 7044635
    [No Abstract]   [Full Text] [Related]  

  • 33. Improved survival in severely burned animals using intravenous Corynebacterium parvum vaccine post injury.
    Stinnett JD; Alexander JW; Morris MJ; Dreffer RL; Craycraft TK; Anderson PE; Ogle CK; MacMillan BG
    Surgery; 1981 Feb; 89(2):237-42. PubMed ID: 7455909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coparvax for malignant effusion?
    Drug Ther Bull; 1983 Oct; 21(20):79-80. PubMed ID: 6641514
    [No Abstract]   [Full Text] [Related]  

  • 35. Corynebacterium parvum and metastatic breast cancer.
    Haskell CM; Sarna GP; Liu PY
    Br J Cancer; 1982 May; 45(5):794-5. PubMed ID: 7044404
    [No Abstract]   [Full Text] [Related]  

  • 36. [Preventive immunization and immunotherapy of Ehrlich carcinoma and Crocker sarcoma in mice].
    Zatula DG
    Biull Eksp Biol Med; 1969; 67(1):62-4. PubMed ID: 5404408
    [No Abstract]   [Full Text] [Related]  

  • 37. Characteristics of resistance to Listeria monocytogenes enhanced by Corynebacterium parvum in mice.
    Miyata H; Nomoto K; Takeya K
    Immunology; 1980 May; 40(1):33-9. PubMed ID: 6968291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the combined treatment of Crocker sarcoma 180 of the mouse with roentgen rays and chlorpromazine].
    Barth G; Krieg R; Valentiner W
    Strahlentherapie; 1968 Nov; 136(5):588-95. PubMed ID: 5708885
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of arginine butyrate on bacterial growth.
    Raymond J; Chany C
    Biomed Pharmacother; 1986; 40(9):352-5. PubMed ID: 3828482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and purification of phosphate dependent glutaminase from sarcoma-180 tumor and its antineoplastic effects on murine model system.
    Maity P; Chakraborty S; Bhattacharya P; Sarkar R
    J Exp Clin Cancer Res; 1999 Dec; 18(4):475-80. PubMed ID: 10746973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.